2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
2010/08/10 by Daniel Aletaha, Tuhina Neogi, Alan J. Silman +37 · 49 citations
Medicine · #Rheumatoid Arthritis Research and Therapies #Spondyloarthritis Studies and Treatments #Musculoskeletal Disorders and Rehabilitation
paper · pdf · doi:10.1002/art.27584
Abstract
OBJECTIVE: The 1987 American College of Rheumatology (ACR; formerly, the American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized for their lack of sensitivity in early disease. This work was undertaken to develop new classification criteria for RA. METHODS: A joint working group from the ACR and the European League Against Rheumatism developed, in 3 phases, a new approach to classifying RA. The work focused on identifying, among patients newly presenting with undifferentiated inflammatory synovitis, factors that best discriminated between those who were and those who were not at high risk for persistent and/or erosive disease--this being the appropriate current paradigm underlying the disease construct "rheumatoid arthritis." RESULTS: In the new criteria set, classification as "definite RA" is based on the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in 4 domains: number and site of involved joints (score range 0-5), serologic abnormality (score range 0-3), elevated acute-phase response (score range 0-1), and symptom duration (2 levels; range 0-1). CONCLUSION: This new classification system redefines the current paradigm of RA by focusing on features at earlier stages of disease that are associated with persistent and/or erosive disease, rather than defining the disease by its late-stage features. This will refocus attention on the important need for earlier diagnosis and institution of effective disease-suppressing therapy to prevent or minimize the occurrence of the undesirable sequelae that currently comprise the paradigm underlying the disease construct "rheumatoid arthritis."
Cited by
- Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
- Classification of rheumatoid arthritis: Comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria
- Meta‐analysis of neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratio in rheumatoid arthritis
- Association of HLA-DRB1 alleles with rheumatoid arthritis in Split-Dalmatia County in southern Croatia
- The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies
- Clinical profiles associated with rapidly progressive interstitial lung disease in antisynthetase syndrome: A multicentric cohort study (TYPASS study)
- Development and validation of a patient knowledge questionnaire for rheumatoid arthritis (PKQ-RA-11) in Danish and German
- <scp>CD4</scp><sup>+</sup><scp>CD8α<sup>low</sup></scp> T Cell Clonal Expansion Dependent on Costimulation in Patients With Rheumatoid Arthritis
- Rheumatoid Arthritis: The Continuum of Disease and Strategies for Prediction, Early Intervention, and Prevention
- Treatment of 139 Pregnancies in Antiphospholipid-positive Women Not Fulfilling Criteria for Antiphospholipid Syndrome: A Retrospective Study
- PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors
- Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis
- Splenectomy at early stage of autoimmune arthritis delayed inflammatory response and reduced joint deterioration in mice
- Rheumatoid Arthritis Treatment Has Changed Dramatically Over the Past 3 Decades, but Has the Disease Itself Changed?
- Altered neutrophil signalling linked to impaired chemotaxis and increased ROS and NET production in older people with frailty
- Participant preferences for the return of non-genetic research results: An interview study of participants from a rheumatoid arthritis trial
- Differential response of tissue engineered skeletal muscle from rheumatoid arthritis patients and healthy controls
- Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial
- Pain in autoimmune disorders
- Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis
- Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials
- Temporomandibular joint problems in patients with rheumatoid arthritis
- Anxiety and depression are common in rheumatoid arthritis and correlate with poor quality of life in Indian patients
- 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. [europepmc]
- A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. [europepmc]
- Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. [europepmc]
- Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-κB. [europepmc]
- Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders. [europepmc]
- Distinctions between diagnostic and classification criteria? [europepmc]
- Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. [europepmc]
- 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. [europepmc]
- 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. [europepmc]
- Evidence of the Immune Relevance of Prevotella copri, a Gut Microbe, in Patients With Rheumatoid Arthritis. [europepmc]
- Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. [europepmc]
- Genetic and environmental risk factors for rheumatoid arthritis. [europepmc]
- Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation. [europepmc]
- Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. [europepmc]
- A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? [europepmc]
- Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer. [europepmc]
- HBEGF + macrophages in rheumatoid arthritis induce fibroblast invasiveness. [europepmc]
- Distinct fibroblast subsets drive inflammation and damage in arthritis. [europepmc]
- Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial. [europepmc]
- Methotrexate an Old Drug with New Tricks. [europepmc]
- Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. [europepmc]
- Formation of a protein corona on the surface of extracellular vesicles in blood plasma. [europepmc]
- Management of Rheumatoid Arthritis: An Overview. [europepmc]
- Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells. [europepmc]
- Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. [europepmc]
Related